Early research (Phase 1)Ended earlyNCT01145014
What this trial is testing
To Investigate Safety, Tolerability, and Pharmacokinetics of Treatment With BI 660848 Rising Single Doses (From 2 mg to 600 mg) Administered as Oral Drinking Solution (Powder in Bottle).
Who this might be right for
PainHealthy
Boehringer Ingelheim 72